Valuation: Epigral Limited

Market Cap 46.69B 488M 419M 391M 359M 675M 686M 4.62B 1.81B 23.42B 1.83B 1.79B 77.42B P/E 2027 *
13.5x
P/E 2028 * 10.6x
Enterprise Value 52.6B 550M 472M 441M 404M 761M 773M 5.2B 2.04B 26.38B 2.07B 2.02B 87.23B EV / Sales 2027 *
1.7x
EV / Sales 2028 * 1.4x
Free-Float
31.14%
Yield 2027 *
0.51%
Yield 2028 * 0.51%
1 day+0.24%
1 week-2.23%
Current month-0.60%
1 month+2.88%
3 months-10.11%
6 months+7.95%
Current year-11.30%
1 week 1,054.6
Extreme 1054.6
1,125
1 month 1,042.2
Extreme 1042.2
1,214
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,911.6
3 years 807
Extreme 807
2,406.75
5 years 426.75
Extreme 426.75
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 75 2017-05-17
Director/Board Member 43 2016-10-04
Director/Board Member 41 2017-05-17
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%-2.23%-42.45%+22.03% 486M
-0.16%-2.85%+1.92%+25.62% 123B
-6.25%-1.32%+305.41%+182.38% 49.66B
-0.20%-3.32%-16.39%-42.77% 39.63B
+0.85%-2.33%+17.83%-19.51% 34.01B
+0.47%-0.55%+53.14%+73.21% 25.4B
+1.12%+3.25%+24.76%-32.17% 21.1B
-6.33%-2.66%+322.76%+613.00% 19.94B
-2.76%+5.07%+31.85%+353.50% 19.15B
-4.01%-8.28%+51.76%+220.85% 18.26B
Average -1.70%+0.60%+75.06%+139.61% 35.07B
Weighted average by Cap. -1.50%-0.42%+71.86%+97.14%

Financials

2027 *2028 *
Net sales 30.88B 323M 277M 259M 237M 446M 454M 3.05B 1.2B 15.48B 1.21B 1.19B 51.2B 37.28B 390M 335M 312M 287M 539M 548M 3.69B 1.44B 18.7B 1.46B 1.43B 61.81B
Net income 3.47B 36.26M 31.1M 29.04M 26.65M 50.11M 50.93M 343M 134M 1.74B 136M 133M 5.75B 4.4B 46M 39.46M 36.85M 33.81M 63.57M 64.62M 435M 170M 2.21B 173M 169M 7.29B
Net Debt 5.92B 61.9M 53.1M 49.58M 45.49M 85.54M 86.95M 585M 229M 2.97B 232M 227M 9.81B 5.49B 57.42M 49.26M 45.99M 42.2M 79.35M 80.66M 543M 213M 2.75B 216M 211M 9.1B
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-08-18 1,082.20 +0.24% 118,759
26-08-18 ₹1,079.60 -1.60% 38,584
26-08-17 ₹1,097.10 -0.12% 42,312
26-08-14 ₹1,098.40 -1.63% 88,349
26-08-13 ₹1,116.60 +1.42% 27,215
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,082.20INR
Average target price
1,728.00INR
Spread / Average Target
+59.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock